Continuing with some good news amidst the pandemic:? IQVIA, an Analytics and CRO services firm, has launched a new matchmaking trial service to accelerate treatment and vaccine development for COVID-19:
The COVID-19 Trial Matching Tool runs at c19trials.com, which IQVIA says is one of the world?s first online platforms that matches individuals with specific COVID-19 studies, and it hopes it will help speed up clinical research projects.
It's a pretty novel way to bring patients into the process:
IQVIA, borne in 2017 from the megamerger between Quintiles and IMS Health, said it is hoping to do its bit to help speed things along with its Matching Tool. It works by combining publicly available information, IQVIA data and tools and an ?algorithmic logic? that creates a questionnaire, dependent on previous responses, to match patients and study investigators to speed up ongoing COVID-19 clinical research projects within the U.S.
Patients can ?easily and quickly navigate? an otherwise complex search process to find relevant trial options for them, thus getting more people in COVID-19 trials more quickly, the company said.
It's important to remember that companies being ready to run clinical trials on a new treatment or vaccine is only part of the battle - we also need patients who are ready to participate in the trials.? Let's hope this helps speed the process of matching patients and trial studies!